Literature DB >> 19079202

Immune reconstitution in the sigmoid colon after long-term HIV therapy.

P M Sheth1, D Chege, L Y Y Shin, S Huibner, F-Y Yue, M Loutfy, R Halpenny, D Persad, C Kovacs, T-W Chun, G Kandel, M Ostrowski, R Kaul.   

Abstract

Early and profound CD4+ T-cell depletion in gut-associated lymphoid tissue (GALT) may drive Human Immunodeficiency Virus (HIV) immunopathogenesis, and GALT immune reconstitution on highly active antiretroviral therapy (HAART) may be suboptimal. Blood and sigmoid colon biopsies were collected from HAART-treated individuals with undetectable blood HIV RNA for > or =4 years and from uninfected controls. HIV proviral levels and T-cell phenotype/function were examined in both compartments. CD4+ T-cell reconstitution in the sigmoid, including CD4+ T cells expressing CCR5, exceeded that in blood and did not differ from uninfected controls. Sigmoid HIV proviral load was not correlated with CD4+ reconsitution, but was correlated with the degree of mucosal CD8+ T-cell immune activation. Colonic Gag-specific T-cell responses were common, but were not associated with proviral load or immune activation. In this select study population, long-term HAART was associated with complete CD4+ T-cell reconstitution in sigmoid colon. However, colonic immune activation may drive ongoing HIV replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079202     DOI: 10.1038/mi.2008.23

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  33 in total

Review 1.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques.

Authors:  Enrico Lugli; Yvonne M Mueller; Mark G Lewis; Francois Villinger; Peter D Katsikis; Mario Roederer
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

3.  Intestinal CD4 Depletion in HIV / SIV Infection.

Authors:  Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

Review 4.  HIV therapeutic vaccines: moving towards a functional cure.

Authors:  Geetha H Mylvaganam; Guido Silvestri; Rama Rao Amara
Journal:  Curr Opin Immunol       Date:  2015-05-18       Impact factor: 7.486

5.  The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection.

Authors:  Binhua Ling; Mahesh Mohan; Andrew A Lackner; Linda C Green; Preston A Marx; Lara A Doyle; Ronald S Veazey
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

Review 6.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

7.  Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy.

Authors:  Nonhlanhla N Mkhize; Pamela P Gumbi; Lenine J Liebenberg; Yuan Ren; Peter Smith; Lynette Denny; Jo-Ann S Passmore
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 8.  Residual inflammation and viral reservoirs: alliance against an HIV cure.

Authors:  Marta Massanella; Rémi Fromentin; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

9.  HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.

Authors:  Barbara L Shacklett; Peter A Anton
Journal:  Curr Infect Dis Rep       Date:  2010-01-13       Impact factor: 3.725

10.  Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels.

Authors:  E J Ciccone; S W Read; P J Mannon; M D Yao; J N Hodge; R Dewar; C L Chairez; M A Proschan; J A Kovacs; I Sereti
Journal:  Mucosal Immunol       Date:  2009-12-02       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.